|
Asset Impairments, Restructuring, and Other Special Charges (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
| Severance Costs | $ 251.8 | $ 142.0 | $ 99.0 |
| Asset Impairment Charges | 149.6 | 50.0 | 363.7 |
| Product Liability Accrual, Period Expense | 230.0 | ||
| Restructuring, Settlement and Impairment Provisions, Total | 401.4 | 192.0 | 692.7 |
|
Tippecanoe Lab [Member]
|
|||
| Severance Costs | 61.1 | ||
| Asset Impairment Charges | 363.7 | ||
|
Xigris [Member]
|
|||
| Asset Impairment Charges | 85.0 | ||
|
Zyprexa [Member]
|
|||
| Product Liability Accrual, Period Expense | 230.0 | ||
|
Leases [Member]
|
|||
| Asset Impairment Charges | $ 56.1 | $ 50.0 | |
| X | ||||||||||
|
- Definition
The charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of loss reported during the period pertaining to product liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination or a discontinued operation as defined by generally accepted accounting principles and costs associated with one-time termination benefits. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|